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Limited information exists on the incidence and char-
acteristics of invasive group A streptococcal (GAS) infec-
tions among residents of long-term care facilities (LTCFs). 
We reviewed cases of invasive GAS infections occurring 
among persons >65 years of age identiﬁ  ed through active, 
population-based surveillance from 1998 through 2003. We 
identiﬁ  ed 1,762 invasive GAS cases among persons >65 
years, including 1,662 with known residence type (LTCF 
or community). Incidence of invasive GAS infection among 
LTCF residents compared to community-based elderly was 
41.0 versus 6.9 cases per 100,000 population. LTCF case-
patients were 1.5 times as likely to die from the infection 
as community-based case-patients (33% vs. 21%, p<0.01) 
but were less often hospitalized (90% vs. 95%, p<0.01). In 
multivariate logistic regression modeling, LTCF residence 
remained an independent predictor of death. Additional 
prevention strategies against GAS infection in this high-risk 
population are urgently needed.
A
lthough group A Streptococcus (GAS) most common-
ly causes pharyngitis and soft tissue infections (1), it 
also produces severe invasive disease including bacteremia, 
pneumonia, necrotizing fasciitis (NF), and streptococcal 
toxic shock syndrome (STSS), especially at the extremes 
of age (2,3). In the United States, 9,000–11,000 cases and 
1,100–1,800 deaths from invasive GAS infection occur 
each year (3). Those >65 years of age have the highest in-
cidence and case-fatality rate: nearly a third of all cases and 
half of all deaths occur in this age group (3). In addition to 
advanced age, cardiac and vascular disease, diabetes, skin 
breakdown, corticosteroid use, and malignancy are associ-
ated with increased risk for invasive GAS infection among 
adults (4–8). Because underlying conditions are common 
among long-term care facility (LTCF) residents, this popu-
lation may be especially vulnerable to invasive GAS infec-
tion. Although outbreaks of invasive GAS infections have 
been well described among LTCF residents (9–16), the 
extent and characteristics of sporadic invasive GAS infec-
tions in this population have not been well deﬁ  ned.
Since 1998, the Active Bacterial Core surveillance 
(ABCs) of the Emerging Infections Program Network 
(EIP)—a collaboration between the Centers for Disease 
Control and Prevention (CDC), state health departments, 
and academic centers—has collected information on resi-
dence (LTCF vs. community) of invasive GAS case-pa-
tients. We used ABCs data to compare incidence, charac-
teristics, and factors contributing to death from invasive 
GAS infections of elderly LTCF residents and similar-aged 
persons residing in the community.
Methods
Surveillance
ABCs conducts active laboratory- and population-
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based surveillance for invasive infections due to GAS and 
other bacterial pathogens of public health importance. We 
reviewed ABCs reports of invasive GAS cases among 
persons >65 years of age occurring from January 1, 1998, 
through December 31, 2003, in the following sites: San 
Francisco, California (3 counties); Baltimore, Maryland (6 
counties); Albany and Rochester, New York (15 counties); 
Portland, Oregon (3 counties); Chattanooga, Knoxville, 
Memphis, and Nashville, Tennessee (11 counties); and the 
entire states of Connecticut, Georgia, and Minnesota. Five 
counties in the Denver, Colorado, metropolitan area were 
added in 2000. The total surveillance area encompassed a 
2000 Census population of 3,446,404 persons >65 years of 
age (10% of the total US population in this age group).
ABCs methodology has been published previously 
(2,17). Brieﬂ  y, ABCs sites maintain active contact with 
clinical laboratories to identify all cases and perform au-
dits of laboratory records at least every 6 months to ensure 
complete reporting. Surveillance ofﬁ  cers review case-pa-
tient medical records to obtain information on demographic 
characteristics, clinical syndrome, underlying disease, and 
illness outcome. Case-patients with GAS-positive blood 
cultures but without an identiﬁ  able clinical syndrome are 
categorized as having bacteremia without focus. Other-
wise, multiple clinical syndromes—including cases of 
pneumonia, cellulitis, osteomyelitis, non-skin abscesses, 
and other syndromes (18) when accompanied by a sterile 
site isolate—may be reported for each case. Underlying 
illness information (18) was not consistently collected in 
Georgia from 1998–1999, Maryland from 1998–2000, or 
Tennessee in 1998. Information on smoking status was col-
lected beginning in 2000 and history of cerebrovascular ac-
cident (CVA) in 2001.
Case Deﬁ  nitions
ABCs deﬁ  nes a case of invasive GAS infection as 
isolation of GAS from a normally sterile site (e.g., blood, 
cerebrospinal ﬂ  uid) or from a wound when accompanied 
by STSS or NF in a resident of an ABCs surveillance area. 
ABCs deﬁ  nes an LTCF as a skilled nursing facility, nursing 
home, rehabilitation hospital, or other chronic-care facility 
in which the patient has been living for at least 30 days 
before GAS infection. The deﬁ  nition did not include facili-
ties in which the patient receives daily outpatient therapy or 
prisons, group homes, and assisted living facilities.
To determine whether outbreaks contributed signiﬁ  -
cantly to GAS disease among LTCF residents, we looked 
for clusters within LTCFs. We deﬁ  ned a GAS LTCF clus-
ter as >2 invasive infections with the same emm type oc-
curring within 12 months (duration of some previously re-
ported GAS outbreaks [10]) among residents >65 years of 
age living at the same facility. Surveillance staff conﬁ  rmed 
the residence of case-patients within each cluster.
Descriptive Epidemiology
To describe incidence trends for persons >65 years of 
age (regardless of residence type) from 1998 to 2003, we 
analyzed GAS cases and deaths reported from 54 ABCs 
counties that conducted GAS surveillance during the en-
tire 6-year period (1998 population: 1,981,662 persons >65 
years of age). For annual rate calculations, we used national 
census and postcensus population estimates for these coun-
ties as the annual population denominators.
To calculate incidence of invasive GAS infection 
among persons >65 years of age stratiﬁ  ed by residence type, 
we included ABCs GAS case-patients during the year 2000 
and imputed cases with missing residence information on 
the basis of distribution of cases with known residence. For 
the denominator we used residence type–speciﬁ  c popula-
tion estimates from the US Census 2000 Summary File 1 
for ABCs counties (19); census data on residence type were 
only available for the year 2000. To calculate national es-
timates of disease, we applied age- and race-speciﬁ  c GAS 
rates from the ABCs surveillance area to the age and racial 
distribution of the US population in 2000; we redistributed 
those of unknown race on the basis of the reported distribu-
tion for known cases.
For residence-speciﬁ   c analyses, we excluded cases 
of invasive GAS infection if residence was missing or un-
known. To calculate case-fatality ratios (CFRs) we includ-
ed only case-patients with known outcomes.
Microbiologic Testing
ABCs sites forwarded all available GAS isolates to 
CDC’s Streptococcal Genetics Laboratory. GAS isolates 
underwent T typing and amplicon restriction proﬁ  ling of 
the emm gene as described at www.cdc.gov/ncidod/bio-
tech/strep/protocol_emm-type.htm (20). Using a reference 
database containing ≈180 group A streptococcal emm se-
quence types, we categorized an isolate as a given emm 
type if it had >92% identity over the ﬁ  rst 30 codons encod-
ing the processed M protein with one of the reference emm 
types (21).
Antimicrobial drug susceptibility testing of available 
GAS isolates in 1999, 2001, and 2003 was performed at 
CDC by using broth microdilution. To report antimicrobial 
susceptibility, we used established Clinical and Laboratory 
Standards Institute breakpoints for MICs and deﬁ  ned iso-
lates with intermediate or high-level resistance as nonsus-
ceptible (22).
Statistical Analysis
We used SAS version 9.1 (SAS Institute Inc., Cary, 
NC, USA) for all analyses. To analyze incidence trends, 
we used Cochran-Armitage calculations for linearity and 
trend. In univariate analysis, we used Cochran-Mantel-
Haenszel statistics to compare case-patient and GAS iso-
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late characteristics stratiﬁ  ed by case-patient residence; we 
also analyzed factors associated with death among LTCF 
residents and community-based case-patients separately.
We used logistic regression to characterize factors as-
sociated with death, checking for 2-way interactions and 
collinearity. We included in our model all variables associ-
ated with death on univariate analysis (p<0.15) controlling 
for age group, race, and sex. We stratiﬁ  ed emm type into 
each of the 10 most common emm types and an 11th cate-
gory including all remaining emm types (“other”). We clas-
siﬁ  ed case-patients with multiple clinical syndromes in the 
category with the highest CFR. The model was restricted to 
cases for which information on all variables was available. 
We considered p values <0.05 statistically signiﬁ  cant.
Results
Disease Incidence and Estimated Disease Impact in 
the Elderly
From 1998 to 2003, a total of 5,889 cases of invasive 
GAS infection of all ages were reported, including 1,762 
(30%) among persons >65 years of age. Incidence of inva-
sive GAS infection in this elderly age group increased from 
10.0 cases per 100,000 population in 1998 to 10.9 cases per 
100,000 population in 2003 (Table 1). Type of residence 
was available for 1,662 elderly case-patients (94%). Of 
these, 383 case-patients resided in LTCFs, accounting for 
23% of cases in those >65 years of age. In 2000 (the only 
year with reliable US Census population estimates for resi-
dence type), the incidence of invasive GAS among LTCF 
residents was almost 6 times higher than among communi-
ty-based residents (41.0 vs. 6.9 cases per 100,000 persons, 
p<0.01). Projecting to the US population, we estimate that 
650 cases among LTCF-residents and 2,250 cases among 
community-based residents >65 years of age occurred na-
tionwide in 2000. Among both LTCF- and community-
based residents, GAS incidence was highest among black 
men (78.9 and 13.8 cases per 100,000 persons, respective-
ly) and lowest among white women (35.1 and 4.9 cases per 
100,000 persons, respectively).
Demographic and Clinical Characteristics
In comparison to community-based case-patients, 
LTCF case-patients were older (median 83 years vs. 75 
years for community case-patients, p<0.01) and more fre-
quently female (Table 2). Underlying illness information 
was available for 1,538 (93%) case-patients. Congestive 
heart failure (CHF), diabetes mellitus, chronic obstruc-
tive pulmonary disease, and atherosclerotic cardiovascu-
lar disease were common in both groups. However, LTCF 
case-patients more frequently had CHF and a history of 
cerebrovascular accident but less commonly had diabetes 
mellitus or were current smokers than community-based 
case-patients. In addition, LTCF residents were less likely 
to have penetrating trauma preceding the infection (0.8% 
vs. 2.7%, p<0.05). Compared to community-based case-pa-
tients, LTCF case-patients more commonly had bacteremia 
without focus and pneumonia but less frequently had cuta-
neous or soft tissue infections as the possible source of the 
invasive GAS isolate identiﬁ  ed (Table 3).
Isolate Characteristics
GAS was identiﬁ  ed from blood cultures in 1,491 
(90%) of the 1,662 elderly case-patients with known 
residence. Of the remaining 171 nonbacteremic patients, 
GAS was most commonly isolated from joint ﬂ  uid (n = 
57) and surgical specimens (n = 51). GAS was identiﬁ  ed 
from multiple body sites in 125 (8%) case-patients.
GAS isolates were available in 1,414 (85%) of the 
1,662 case-patients. From a total of 63 emm types identi-
ﬁ  ed, 5 (emm1, emm3, emm12, emm28, and emm89) ac-
counted for most infections (57% among LTCF residents; 
62% among community-based residents) (Table 4). An-
timicrobial susceptibility testing was performed on 781 
GAS isolates including 187 isolates from LTCF case-pa-
tients. Fourteen (7%) isolates from LTCF case-patients 
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Table 1. Invasive group A streptococcal infection cases and deaths among persons age >65 y, by site, ABCs areas, 1998–2003* 
1998 1999 2000 2001 2002 2003
No. cases/100,000 population 
 CA 8.4 10.3 11.1 9.8 7.6 9.5
 CT 8.7 9.4 11.3 9.8 10.2 11.5
 GA 10.5 7.3 9.7 12.5 6.4 9.5
 MD 13.7 9.0 9.3 15.4 11.4 15.3
 MN 11.4 10.5 10.6 13.1 10.3 9.8
 NY 7.7 12.6 10.3 10.2 12.9 10.2
 OR 9.2 6.5 4.0 4.6 6.6 9.0
 All  sites 10.0 9.3 10.0 11.1 9.2 10.9
No. deaths/100,000 population 
 All  sites 2.2 1.9 2.3 2.2 2.2 2.6
*ABCs (Active Bacterial Core surveillance) areas: San Francisco, California (3 counties), Connecticut (entire state), Atlanta, Georgia, metropolitan area 
(20 counties), Baltimore, Maryland (6 counties), Minneapolis/St. Paul, Minnesota (7 counties), Rochester, New York (7 counties), and Portland, Oregon (3 
counties). Group A Streptococcal Infection in Older Adults
and 34 (6%) from community-based case-patients were 
not susceptible to erythromycin (p = 0.38). Three isolates 
from LTCF case-patients and 5 from community case-
patients were not susceptible to levoﬂ   oxacin; 2 from 
community case-patients were not susceptible to clinda-
mycin. No isolates were resistant to penicillin, ampicil-
lin, cefazolin, vancomycin, or cefotaxime.
Predictors of Death
The CFR among case-patients >65 years of age was 
24%. CFR increased with age among both LTCF- and com-
munity-based case-patients. However, when compared to 
the CFR for the 65- to 74-year-old group, the CFR among 
75- to 84-year-old persons and those >85 years of age was 
signiﬁ  cantly greater only among community-based case-
patients (Figure). LTCF case-patients were 1.5 times as 
likely to die from the infection as community-based GAS 
case-patients (33% vs. 21%, p<0.01); however, this group 
was less often hospitalized (90% vs. 95%, p<0.01). CFRs 
among hospitalized and nonhospitalized case-patients were 
comparable in both LTCF (33% vs. 33%, p = 0.92) and 
community case-patients (21% vs. 25%, p = 0.44).
Univariate analysis of LTCF case-patients showed 
that those with CHF had signiﬁ  cantly higher CFR (42% 
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Table 2. Characteristics of persons age >65 y with invasive group A streptococcal infection by known residence, ABCs areas, 1998–
2003*
Characteristic
No. LTCF  
case-patients (%), n = 383
No. community-based  
case-patients (%), n = 1,279 p value
Age, y <0.01
  65–74 72 (18.8) 584 (45.7)
  75–84 149 (38.9) 465 (36.3)
>85 162 (42.3) 230 (18.0)
Female sex 238 (62.1) 626 (48.9) <0.01
Race† 0.16
  White 282 (82.5) 914 (78.9)
  Black 50 (14.6) 182 (15.7)
  Other 10 (2.9) 63 (5.4)
Case-fatality† 124 (32.6) 268 (21.1) <0.01
Hospitalization† 346 (90.3) 1211 (94.8) <0.01
Presence of underlying illnesses†
  Congestive heart failure 104 (29.3) 237 (20.5) <0.01
  Cerebrovascular accident 39 (16.8) 71 (9.4) <0.01
  Diabetes mellitus 86 (24.2) 346 (30.0) <0.05
  Current smoker 6 (2.1) 61 (6.5) <0.01
  Chronic obstructive pulmonary disease 62 (17.5) 172 (14.9) 0.24
  Atherosclerotic cardiovascular disease 95 (26.7) 351 (30.4) 0.19
  Renal failure/dialysis 30 (8.5) 103 (8.9) 0.78
  Alcohol abuse 19 (5.4) 48 (4.2) 0.34
  Immunosuppressive therapy‡ 19 (5.4) 87 (7.5) 0.16
*ABCs, Active Bacterial Core surveillance;LTCF, long-term care facility. Case-patients with missing responses for residence type or individual 
characteristics were excluded from analysis. 
†Data were not available for all case-patients. Denominators by residence varied for the following: race (LTCF 342, community 1,159), outcome (LTCF 
380, community 1,270), hospitalization (LTCF 383, community 1,278), underlying illnesses (LTCF 355, community 1,154) except for cerebrovascular 
accident (LTCF 232, community 758) and current smoker (LTCF 285, community 936). 
‡Includes steroids, chemotherapy, and radiation therapy. 
Table 3. Clinical syndromes among persons >65 y with invasive group A streptococcal infection, by residence and overall CFR, ABCs 
areas, 1998–2003* 
Clinical syndrome
No. LTCF case-patients (%),  
N = 383
No. community-based  
case-patients (%), N = 1,279 p value
Overall
CFR, %
Bacteremia without focus 145 (37.9) 406 (31.7) <0.05 25.1
Pneumonia† 97 (25.3) 225 (17.6) <0.01 34.0
Cellulitis† 121 (31.6) 498 (38.9) <0.01 16.3
Septic arthritis† 20 (5.2) 90 (7.0) 0.21 11.8
Osteomyelitis† 7 (1.8) 26 (2.0) 0.80 6.1
STSS 15 (3.9) 82 (6.4) 0.07 55.7
Necrotizing fasciitis 15 (3.9) 80 (6.3) 0.08 36.6
Abscess†‡ 8 (2.3) 47 (3.9) 0.15 14.5
*CFR, case-fatality ratio; ABCs, Active Bacterial Core surveillance; LTCF, long-term care facility; STSS, streptococcal toxic shock syndrome. Case-
patients with missing responses for residence type, outcome, or clinical syndrome were excluded from analysis. Data for case-patients could be 
categorized under >1 syndrome except for case-patients identified as having bacteremia without a focus. 
†Occurring in conjunction with isolation of group A streptococcal infection from a sterile site (e.g., blood culture). 
‡Data not available for all years. Denominators: LTCF 349; community 1,205. RESEARCH
with CHF died vs. 27% without CHF, p<0.01) as did those 
with infections caused by emm1 (51% vs. 28%, p<0.01) 
or emm3 (45% vs. 30%, p<0.05) when compared to other 
emm types. We also observed higher CFR among LTCF 
case-patients with STSS (73% vs. 31%, p<0.01), NF (64% 
vs. 31%, p<0.05), or pneumonia (42% vs. 30%, p<0.05) 
than those with other syndromes. Sex, race, and hospital-
ization of LTCF case-patients were not signiﬁ  cantly associ-
ated with death. These same variables were associated with 
signiﬁ  cantly higher case-fatality rates among community-
based case-patients.
In the ﬁ  nal multivariate logistic regression model, in-
dependent predictors of death included LTCF residence; 
lack of hospitalization; infection due to emm1, emm3, or 
emm12; disease manifesting as STSS, NF, pneumonia, or 
bacteremia without focus; and interaction between female 
sex and presence of congestive heart failure (Table 5). Age 
was not a signiﬁ  cant risk factor associated with death.
Clustering of Cases
We identiﬁ  ed 18 GAS clusters comprising a total of 
40 cases (10% of LTCF cases). Fourteen clusters consisted 
of only 2 cases; the other 4 clusters had 3 cases each. The 
median interval between the ﬁ  rst and second cases was 2.5 
months (range 0.2–9.2 months). The most common emm 
types identiﬁ  ed were emm28 and emm89, which caused 4 
and 3 clusters, respectively. Case-patients in clusters were 
of similar age (median 85.5 years), sex (68% female), and 
race (75% white) to overall LTCF GAS case-patients >65 
years of age. The most common syndromes of clustered 
patients were cellulitis (40%) and bacteremia without focus 
(38%). Fifteen case-patients died (CFR 38%).
Discussion
Although the elderly have the highest rates of disease 
and death due to invasive GAS infection (2–4), we demon-
strated that a subset of persons >65 years of age has an even 
greater risk. Invasive GAS infection was almost 6 times as 
likely to develop in elderly LTCF residents. Moreover, such 
case-patients were 1.5 times more likely to die from this in-
fection than elderly persons living in the community. LTCF 
case-patients with invasive GAS infection were more likely 
to be older, female, have a history of CHF or CVA, and 
have pneumonia or bacteremia without focus compared to 
community-based case-patients. We found no signiﬁ  cant 
differences in emm type distributions and antimicrobial 
resistance patterns among GAS isolates that caused infec-
tions in LTCF- or community-based case-patients.
The increased risk for death among elderly case-pa-
tients living in LTCFs compared to case-patients in the 
community remained signiﬁ  cant on multivariate analysis 
and is likely attributable, in part, to the fact that LTCF resi-
dence is a proxy measure of individual frailty. While this 
surveillance system collects information such as age and 
underlying conditions, measurements of functional status 
such as the Karnofsky score or activities of daily living 
are not obtained. The common use of advanced directives 
among LTCF residents may also contribute to the higher 
CFR. Because some directives preclude aggressive clinical 
management, this may also explain the lower frequency of 
hospitalization among LTCF case-patients.
Other factors associated with higher CFR included 
speciﬁ  c emm types and several clinical syndromes. These 
ﬁ  ndings are consistent with past studies in which disease 
due to emm types 1 and 3 as well as the clinical syndromes 
pneumonia or STSS were independent predictors of death 
among all age groups (2). Although advancing age has been 
found previously to contribute to overall case-fatality rates 
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Table 4. Most common emm types identified in persons >65 y 
with invasive group A streptococcal infection, by residence, ABCs 
areas, 1998–2003* 
emm type
No. LTCF case-patients 
(%), N = 324
No. community-based 
case-patients (%),  
N = 1,090
1 55 (17.0) 233 (21.4)
3 44 (13.6) 141 (12.9)
28 39 (12.0) 122 (11.2)
12 21 (6.5) 116 (10.6)
89 27 (8.3) 61 (5.6)
77 9 (2.8) 39 (3.6)
6 12 (3.7) 22 (2.0)
18 6 (1.9) 28 (2.6)
11 10 (3.1) 23 (2.1)
4 11 (3.4) 21 (1.9)
*ABCs, Active Bacterial Core surveillance; LTCF, long-term care facility. 
Case-patients with missing responses for residence type and emm type 
were excluded from analysis. Table stratified by overall frequency. 
Figure. Comparison of case-fatality ratio from invasive group A 
streptococcal infections among persons by age group and residence, 
Active Bacterial Core surveillance areas, 1998–2003. Blank square, 
long-term care facility case-patient; black square, community-based 
case-patient. Case-patients with missing responses for residence 
type and outcomes were excluded from analysis. *p<0.05 for long-
term care facility case-patients versus community-based case-
patients. †p<0.05 indicates signiﬁ   cance between the following 
groups: 75–84-year age group versus 65–74-year age group, or 
>85-year age group versus 65–74-year age group.Group A Streptococcal Infection in Older Adults
(2,23), our analysis showed advancing age (e.g., age 75–84 
years or >85 years) was no longer signiﬁ  cant once presence 
of CHF, residence type, and emm type were included in the 
statistical model.
The true extent of severe GAS infections in the LTCF 
population is likely greater than our study estimates. First, 
ABCs identiﬁ  es only culture-conﬁ  rmed invasive GAS in-
fections, limiting recognition of GAS syndromes such as 
cellulitis, for which cultures are not commonly obtained. 
Furthermore, current guidelines developed through expert 
opinion do not recommend obtaining blood cultures in resi-
dents of LTCFs, largely because of the low yield of blood 
cultures in this setting (24). Consequently, many LTCF 
practitioners do not routinely obtain blood cultures in resi-
dents with fever; residents are either treated empirically or 
transferred to an acute-care facility (25,26). In our analysis 
of hospitalized LTCF case-patients, only 8% of positive 
GAS cultures were obtained before the day of hospitaliza-
tion. Second, ABCs surveillance personnel have noted that 
residence-type is not always recorded in medical records, 
potentially leading to misclassiﬁ  cation of LTCF residents 
as community residents. However, this misclassiﬁ  cation 
would also underestimate the extent of severe GAS illness 
in the LTCF population.
We used available data to estimate the frequency of 
clusters of invasive GAS infection occurring in LTCFs. 
Although other studies suggest that many cases of inva-
sive GAS may represent secondary transmission (4,23,27), 
we found that only 10% of cases among LTCF residents 
occurred within documented clusters. This ﬁ  nding likely 
represents underreporting for several reasons: use of em-
piric antimicrobial agents in LTCFs for mild and moderate 
infections; presence of disease manifestations for which 
cultures are not routinely obtained (e.g., cellulitis); and ab-
sence of GAS isolates (15%) for emm typing, a criterion we 
used to deﬁ  ne a cluster.
Nonetheless, this study augments ﬁ  ndings from other 
studies that note greater frequency of invasive bacterial 
infections among the elderly (27–29). Prior analyses of in-
vasive group B streptococcal (GBS) and S. pneumoniae in-
fections found that these infections were ≈4 times more com-
mon in LTCF residents than in community-dwelling elderly 
(28,29), likely due to the advanced age, multiple underlying 
conditions, and immobility in this population (30). Crowded 
living quarters may also play a role, as clusters of invasive 
GAS among healthy persons living in close proximity have 
been reported previously (31,32). Although less prevalent 
within nursing homes than illnesses such as urinary tract 
infection, invasive GAS, GBS, and pneumococcal diseases 
remain substantial causes for concern given the associated 
illness and higher deaths with these infections, the risk for 
outbreaks, and emerging antimicrobial resistance.
In addition to improved LTCF infection control prac-
tices, invasive GAS infections could be prevented with the 
use of an effective GAS vaccine. In the past, development 
of a GAS vaccine targeting the M protein, a major viru-
lence determinant, has been halted over concerns of pos-
sible induction of antibodies that cross-react with brain, 
joint, and cardiac tissues (33,34). However, current vaccine 
candidates avoid the risks for cross-reactivity (35,36). Our 
analysis shows that 82% and 85% of strains causing inva-
sive disease in both LTCF and community elderly, respec-
tively, would be covered by the 26-valent M protein-based 
vaccine recently tested in phase II trials. If this vaccine also 
induces a protective response among older adults, it could 
substantially beneﬁ  t LTCF residents.
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Table 5. Results of multivariate logistic regression analysis of 
factors associated with death from invasive group A 
streptococcal infection among case-patients >65 y of age, ABCs 
areas, 1998–2003* 
Characteristic Adjusted odds ratio (95% CI) 
Age group, y
>85 1.4 (0.9–2.1)
 75–84 1.2  (0.8–1.8)
 65–74 Reference
Race
 Black 0.8  (0.5–1.2)
 Other  than  black Reference
Residence
Long-term care facility 1.6 (1.1–2.2)
 Community Reference
Hospitalized
Hospitalized 0.5 (0.3–0.9)
 Not  hospitalized Reference
Syndrome
Bacteremia without focus 2.6 (1.7–3.8)
Pneumonia 3.7 (2.4–5.8)
Necrotizing fasciitis 3.6 (1.7–7.4)
STSS 11.1 (6.4–19.3)
 Other  syndrome Reference
emm type
emm1 2.3 (1.4–3.6)
 emm3 1.9 (1.1–3.1)
emm4 1.7 (0.6–4.5)
emm6 0.6 (0.2–2.1)
emm11 0.4 (0.1–2.0)
emm12 1.9 (1.1–3.4)
emm18 1.3 (0.5–3.9)
emm28 0.9 (0.5–1.7)
emm77 1.3 (0.5–3.4)
emm89 1.5 (0.8–3.0)
 Other  emm types Reference
Sex and history of CHF†
Females with CHF 2.4 (1.5–3.8)
  Females without CHF 0.9 (0.7–1.4)
  Males with CHF 1.2 (0.7–2.0)
 Males  without  CHF Reference
*ABCs, Active Bacterial Core Surveillance; CI, confidence interval; STSS, 
streptococcal toxic shock syndrome; CHF, congestive heart failure. A total 
of 1,140 case-patients with complete data were included in the final model.
Significant results are shown in boldface.
†Interaction between sex and history of CHF. RESEARCH
In conclusion, our analysis noted that all older adults, 
but particularly those living in LTCFs, have signiﬁ  cantly 
higher rates of disease and death from invasive GAS infec-
tion. This institutionalized population represents a unique 
opportunity for prevention through enhanced surveillance 
to improve case detection and secondary disease preven-
tion, stringent infection control measures, and annual im-
munization against inﬂ  uenza, a disease for which GAS is a 
known secondary infection (14,16,23). Finally, vaccination 
of this population with an effective GAS vaccine may be 
highly beneﬁ  cial.
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